325 related articles for article (PubMed ID: 29797007)
21. Production of High-Titer Lentiviral Particles for Stable Genetic Modification of Mammalian Cells.
Larcombe MR; Manent J; Chen J; Mishra K; Liu X; Nefzger CM
Methods Mol Biol; 2019; 1940():47-61. PubMed ID: 30788817
[TBL] [Abstract][Full Text] [Related]
22. Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range.
Beyer WR; Westphal M; Ostertag W; von Laer D
J Virol; 2002 Feb; 76(3):1488-95. PubMed ID: 11773421
[TBL] [Abstract][Full Text] [Related]
23. Production and titration of lentiviral vectors.
Barde I; Salmon P; Trono D
Curr Protoc Neurosci; 2010 Oct; Chapter 4():Unit 4.21. PubMed ID: 20938923
[TBL] [Abstract][Full Text] [Related]
24. Optimized protocol for high-titer lentivirus production and transduction of primary fibroblasts.
He X; He Q; Yu W; Huang J; Yang M; Chen W; Han W
J Basic Microbiol; 2021 May; 61(5):430-442. PubMed ID: 33683727
[TBL] [Abstract][Full Text] [Related]
25. Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells.
Gama-Norton L; Botezatu L; Herrmann S; Schweizer M; Alves PM; Hauser H; Wirth D
Hum Gene Ther; 2011 Oct; 22(10):1269-79. PubMed ID: 21554103
[TBL] [Abstract][Full Text] [Related]
26. RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.
Stornaiuolo A; Piovani BM; Bossi S; Zucchelli E; Corna S; Salvatori F; Mavilio F; Bordignon C; Rizzardi GP; Bovolenta C
Hum Gene Ther Methods; 2013 Aug; 24(4):228-40. PubMed ID: 23767932
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
28. A stable system for the high-titer production of multiply attenuated lentiviral vectors.
Klages N; Zufferey R; Trono D
Mol Ther; 2000 Aug; 2(2):170-6. PubMed ID: 10947945
[TBL] [Abstract][Full Text] [Related]
29. Creating higher titer lentivirus with caffeine.
Ellis BL; Potts PR; Porteus MH
Hum Gene Ther; 2011 Jan; 22(1):93-100. PubMed ID: 20626321
[TBL] [Abstract][Full Text] [Related]
30. Non-integrating lentiviral vectors based on the minimal S/MAR sequence retain transgene expression in dividing cells.
Xu Z; Chen F; Zhang L; Lu J; Xu P; Liu G; Xie X; Mu W; Wang Y; Liu D
Sci China Life Sci; 2016 Oct; 59(10):1024-1033. PubMed ID: 27614752
[TBL] [Abstract][Full Text] [Related]
31. An Improved Protocol for the Production of Lentiviral Vectors.
Brown LY; Dong W; Kantor B
STAR Protoc; 2020 Dec; 1(3):100152. PubMed ID: 33377046
[TBL] [Abstract][Full Text] [Related]
32. Stable Expression by Lentiviral Transduction of Cells.
Gödecke N; Hauser H; Wirth D
Methods Mol Biol; 2024; 2810():147-159. PubMed ID: 38926278
[TBL] [Abstract][Full Text] [Related]
33. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures.
Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A
J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482
[TBL] [Abstract][Full Text] [Related]
34. Selective transduction of astrocytic and neuronal CNS subpopulations by lentiviral vectors pseudotyped with Chikungunya virus envelope.
Eleftheriadou I; Dieringer M; Poh XY; Sanchez-Garrido J; Gao Y; Sgourou A; Simmons LE; Mazarakis ND
Biomaterials; 2017 Apr; 123():1-14. PubMed ID: 28152379
[TBL] [Abstract][Full Text] [Related]
35. A guide in lentiviral vector production for hard-to-transfect cells, using cardiac-derived c-kit expressing cells as a model system.
Kalidasan V; Ng WH; Ishola OA; Ravichantar N; Tan JJ; Das KT
Sci Rep; 2021 Sep; 11(1):19265. PubMed ID: 34584147
[TBL] [Abstract][Full Text] [Related]
36. Lentiviral vectors--the promise of gene therapy within reach?
Amado RG; Chen IS
Science; 1999 Jul; 285(5428):674-6. PubMed ID: 10454923
[No Abstract] [Full Text] [Related]
37. Systematic determination of the packaging limit of lentiviral vectors.
Kumar M; Keller B; Makalou N; Sutton RE
Hum Gene Ther; 2001 Oct; 12(15):1893-905. PubMed ID: 11589831
[TBL] [Abstract][Full Text] [Related]
38. Optimized Lentiviral Transduction Protocols by Use of a Poloxamer Enhancer, Spinoculation, and scFv-Antibody Fusions to VSV-G.
Anastasov N; Höfig I; Mall S; Krackhardt AM; Thirion C
Methods Mol Biol; 2016; 1448():49-61. PubMed ID: 27317172
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
Bahner I; Sumiyoshi T; Kagoda M; Swartout R; Peterson D; Pepper K; Dorey F; Reiser J; Kohn DB
Mol Ther; 2007 Jan; 15(1):76-85. PubMed ID: 17164778
[TBL] [Abstract][Full Text] [Related]
40. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors.
Kutner RH; Zhang XY; Reiser J
Nat Protoc; 2009; 4(4):495-505. PubMed ID: 19300443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
